Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Interest Expenses (2018 - 2022)

Historic Interest Expenses for Lipocine (LPCN) over the last 5 years, with Q2 2022 value amounting to $7568.0.

  • Lipocine's Interest Expenses fell 8682.18% to $7568.0 in Q2 2022 from the same period last year, while for Mar 2023 it was $7568.0, marking a year-over-year decrease of 9508.08%. This contributed to the annual value of $27098.0 for FY2022, which is 8667.04% down from last year.
  • Latest data reveals that Lipocine reported Interest Expenses of $7568.0 as of Q2 2022, which was down 8682.18% from $19529.0 recorded in Q1 2022.
  • Lipocine's 5-year Interest Expenses high stood at $223789.0 for Q1 2019, and its period low was $7568.0 during Q2 2022.
  • For the 5-year period, Lipocine's Interest Expenses averaged around $118016.9, with its median value being $87847.0 (2020).
  • Its Interest Expenses has fluctuated over the past 5 years, first soared by 1627.46% in 2019, then plummeted by 8682.18% in 2022.
  • Lipocine's Interest Expenses (Quarter) stood at $218577.0 in 2018, then decreased by 29.14% to $154881.0 in 2019, then tumbled by 47.62% to $81133.0 in 2020, then crashed by 60.5% to $32051.0 in 2021, then tumbled by 76.39% to $7568.0 in 2022.
  • Its Interest Expenses stands at $7568.0 for Q2 2022, versus $19529.0 for Q1 2022 and $32051.0 for Q4 2021.